HeartSciences Inc.
Cash Flow Statement
| Line Item | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.8M | $-1.6M | $-1.7M | $-1.4M | $-1.6M | $-1.3M | $-1.8M | $-1.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $9.2K | $3.7K | $7.6K | $7.3K | $6.8K | $6.9K | $6.8K | $6.4K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $78.4K | $96.1K | $105.8K | $124.6K | $99.2K | $1.5K | $1.9K | $145.7K |
| Net Cash from Operating Activities | $-1.6M | $-2.1M | $-988.2K | $-1.4M | $-1.9M | $-1.0M | $-1.1M | $-1.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $48.8K | $8.8K | $2.0K | $4.9K | $7.6K | $3.5K | $0 | $7.2K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-69.2K | $-49.2K | $-2.0K | $-4.9K | $-7.6K | $-3.5K | $0 | $-7.2K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $377.1K | $9.1M | $514.6K | $324.4K | $1.6M | $-121.5K | $-116.4K | $5.2M |
| Net Change in Cash | $-1.3M | $7.0M | $-475.5K | $-1.1M | $-270.5K | $-1.1M | $-1.2M | $3.4M |
| Free Cash Flow | $-1.6M | $-2.1M | $-990.1K | $-1.4M | $-1.9M | $-1.0M | $-1.1M | $-1.8M |